References in periodicals archive ?
Thus, we recommended VP as the drug of the first choice for luteal support in patients undergoing IVF-ET with GnRH-antagonist protocol in young women.
(2003), the leading topics were IVF-ET, infertility, endometriosis, pregnancy, ICSI, and fertility.15 Infertile individuals search similar topics on the Internet.
136 nonpregnant patients among 259 patients in the IVF cycle began to take pentanoic acid estradiol orally at the third day of menstrual period after IVF-ET treatment for 3 months or above.
However, the clinical use of GIFT and related techniques is becoming extremely rare due to drastic improvements in implantation rates associated with IVF-ET.
* Eight hundred ninety-six age-matched patients with none of the described lesions who also underwent fresh IVF-ET during the same time period.
In women undergoing in vitro fertilization and embryo transfer (IVF-ET), serial measurements of 17[beta]-estradiol ([E.sub.2]) can be used to monitor follicular growth, and serum
[9.] See, for example, Medical Research International, "In Vitro Fertilization-Embryo Transfer (IVF-ET) in the United States: 1989 Results from the IVF-ET Registry," Fertility and Sterility 55, no.
The first baby conceived by IVF-ET was born in 1978.
Her current pregnancy was conceived after in vitro fertilization and embryo transfer (IVF-ET) following gonadotrophin-releasing hormone antagonist treatment for endometriosis.
We present a rare case of a 23-year-old woman with a twin pregnancy following in vitro fertilization-embryo transfer (IVF-ET) who presented with symptoms of intestinal obstruction at 22+4 weeks of gestation.
A case of twin pregnancy with complete hydatidiform mole and coexisting fetus following IVF-ET. J Assist Reprod Genet 2002;19(3):144-8.